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ABSTRACT
Recently, an increasing number of pharmacists had to supply
medicinal products based on Cannabis sativa L. (Cannaba-
ceae), prescribed by physicians to individual patients. Canna-
bis olive oil preparation is the first choice as a concentrated
extract of cannabinoids, even though standardized operative
conditions for obtaining it are still not available. In this work,
the impact of temperature and extraction time on the con-
centration of active principles was studied to harmonize the
different compounding methods, optimize the extraction
process, and reduce the variability among preparations.
Moreover, starting from the cannabis inflorescence, the effect
of temperature on tetrahydrocannabinolic acid decarboxyla-
tion was evaluated. For the analysis, a GC/MS method, as sug-
gested by the Italian Ministry of Health, and a GC/flame ion-
ization detection method were developed, validated, and
compared.
Extraction Method and Analysis of Cannabinoids
in Cannabis Olive Oil Preparations
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l.Introduction
The medicinal use of Cannabis sativa L., (Cannabaceae), herein-
after cannabis, is being intensively investigated. The most com-
mon therapeutic indications [1] of C. sativa are undernutrition,
chemotherapy-induced nausea and vomiting [2], neuropathic
pain [3], spasticity and seizure in multiple sclerosis [4], glaucoma,
and improving sleep [5]. Currently, only two cannabis-based me-
dicinal products have obtained marketing authorization. They
contain 1) the synthetic isomer of delta-9-tetrahydrocannabinol
(THC) dronabinol (Marinol, AbbVie Inc.), used to manage loss of
appetite associated with weight loss in acquired immune deficien-
cy syndrome (AIDS) and nausea and vomiting associated with can-
cer chemotherapy in patients who have failed to respond ade-
quately to conventional treatments or 2) the synthetic cannabi-
noid nabilone (Cesamet, Meda Pharmaceuticals Inc.). Another
cannabis-based medicinal product is nabiximols (Sativex, GW
Pharma Ltd.), a specific extract of C. sativa, used in multiple scle-
rosis to improve symptoms related to muscle stiffness, i.e., “spas-Casiraghi A et al. Extraction Method and… Planta Medticity”. Seven other industrial pharmaceutical drugs based on can-
nabinoids are under development. Dried female flower tops of the
cannabis plant are also available as standardized medicinal grade
material. This possibility of treatment is a promising opportunity,
as significant evidences show that plant-based medications are
vastly superior to synthetic drugs because of a complex cannabi-
noid/terpene combination known as the “Entourage Effect” [1,6].
The use of the cannabis plant, vaporized or orally ingested, is ad-
mitted in several European countries. In the USA, it is not ap-
proved by Food and Drug Administration (FDA), even though it is
legally allowed for certain medical conditions in several States [7].
C. sativa L. belongs to the family Cannabaceae, and is an annual
dioecious plant with stems up to 2–5m high, 3 to 9 palmatisect,
alternate leaves with lanceolate, acute and serrate lobes, smooth
nuts, and erect and glandular inflorescences: the male much
branched, the female racemose [8].
THC, the main psychoactive constituent of C. sativa, and can-
nabidiol (CBD) are present in the plant as tetrahydrocannabinolic
acid (THCA) and cannabidiolic acid (CBDA), respectively. The ac-
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l.idic forms, which are pharmacologically less active [9,10], have to
first be converted to the active neutral compounds. Decarboxyla-
tion is a temperature-dependent event and it can be reached by
heating plant materials. At a few degrees over 100 °C, THCA de-
carboxylizes into THC [11]. At higher temperatures, between 180
and 200°C, the vaporization of the cannabinoids that reside on
the trichomes on the surface of flowers and leaves occurs, while
at even higher temperatures (230 °C and above) combustion
takes place, producing smoke toxins. The outcome of the decar-
boxylation process is strongly influenced by operative conditions
[12].
C. sativa for medical purposes is generally administered by two
routes, either inhaled by means of a vaporizer or orally ingested.
As vaporizers reach about 200 °C, cannabinoids are available in
the decarboxylated form. The oral formulations of cannabis may
be in the form of a liquid extract, e.g., oil or tea, or capsules. After
oral administration, the absorption of cannabinoids is slow and
shows a limited oral pharmacokinetic. On the other hand, this
route of administration is associated with a reduction of damage
[13]. Liquid cannabis extracts may also be administered sublin-
gually. Indeed, Sativex, a liquid extract containing THC and CBD
in a 1 :1 ratio, is available as an oromucosal spray [14].
Extraction in aqueous or organic solvents is a way to obtain a
highly concentrated content of cannabinoids and other beneficial
components. By using water, an herbal tea can be obtained,
whose composition was investigated by Hazekamp et al. [15].
The results indicated that cannabis tea has only limited potency,
as it is probably a saturated solution of THC. Ethanol extracts have
also been evaluated, considering the higher solubility of the active
principles in this solvent than in water [11]. The use of plant oil as
an extraction solvent can be a safe alternative [16].
Recently, due to the approval by the Ministry of Health of a de-
cree that regulates the cultivation, processing, and therapeutic
uses of C. Sativa, there has been an increasing demand for the
compounding of oily extracts obtained from the dried flowers.
The need of a standardized protocol for oily preparations has
grown accordingly, but until now, it has not been devised.
In this context, cannabis extraction was performed using olive
oil and a standardized medicinal cannabis “flos” (according to
pharmaceutical standards), purchased from a Dutch company
and labelled as having a THC level standardized at 19–22% and a
CBD level below 1%. Taking into account the above reported de-
scription of the cannabis fresh plant composition, it should be
supposed that the flowering tops contain the acid forms of the
two cannabinoids and, therefore, the value of 19–22% reported
in the certificate of analysis should be the sum of the content of
THC and THCA. Hazekamp [17] described this composition. More-
over, the chromatograms reported in the Analytical Monography
Cannabis Flos [18] demonstrated that THCA is the major compo-
nent among the active principles.
In this work, following a detailed morphological survey of plant
material, the effect of extraction conditions on oily preparations
and temperature on the cannabinoid decarboxylation in the can-
nabis inflorescence was evaluated. To harmonize extraction meth-
ods and temperatures, the Italian Society of Compounding Phar-
macists (SIFAP) proposed to pharmacists six methods of prepara-
tion. The impact of temperature and extraction time on the con-centration of cannabinoids was studied to optimize the extraction
and reduce the variability among preparations. Moreover, a GC/
MS method, as suggested by the Ministry of Health, and a GC/
FID (flame ionization detection) method were developed and val-
idated, and the performances of the two different detectors were
compared.Results and Discussion
The morphological survey proved that the investigated plant ma-
terial was comprised of female inflorescences. The pistillate flow-
ers of C. sativa are indeed grouped into pairs in crowded, short
pauciflore inflorescences at the axillae or terminals of branches.
The flower consists of one unilocular ovary and of two elongated
and hairy stigmas. A hood-shaped perianth surrounds the ovary, a
typical characteristic of the family Cannabaceae (▶ Fig. 1A,B).
The plant epidermis, especially at the perianth level, is densely
covered by an indumentum composed of diverse kinds of tri-
chomes (▶ Fig. 1C). The investigated samples, even if dried, are
quite well preserved, since trichome morphotypes are easily rec-
ognizable, although the epidermal surface appears deeply col-
lapsed (▶ Fig. 1D).
Hooked hair-like lithocysts are invariably well preserved and
are mostly visible on the leaf surfaces (▶ Fig. 1D,E). Their distri-
bution patterning and the composition of the cystoliths have
been used in the past in the forensic identification of marijuana
[19].
Glandular hairs of various kinds have been described under dif-
ferent, debatable terms over time [20]. We chose, however, to use
the existing terminology and, consistent with the criticism that
emerged in the paper by [21], distinguished two main trichome
groups. The first is-bulbous, with a uni- or bicellular head, a short,
biseriate stalk and a 2-foot cell lying at the level with the epidermis
[21]. We documented their distribution only for leaf laminas
(▶ Fig. 1C). The second group is-capitate, with a head made up
of 8–16 cells arranged in a single disc, surmounted by a wide sub-
cuticular space, and a multiseriate stalk composed of 2–4 cell
rows. The stalk is variable in length due the diverse elongation de-
gree of the epidermal multiseriate foot (pseudo-stalks) support-
ing it. Thus, the so-called capitate-stalked glands and capitate-
sessile glands have been grouped together. They occurred on the
inflorescence axis, on leaves and especially on pistillate bracts
(▶ Fig. 1E–G).
Due to the dense indumentum and to the overall small size of
bulbous hairs, light microscope observations mostly involved cap-
itate glands with long pseudo-stalks.
The localization of cannabinoid production in the head and
stalk of capitate trichomes is largely confirmed by gas-liquid chro-
matographic evidences and by the identification of the candidate
biosynthetic genes [22]. Copious secretory products fully cover-
ing the head and the stalk of capitates were observed
(▶ Fig. 1G–J). These substances appear brown-colored and exhib-
ited primary fluorescence under UV light (▶ Fig. 1H–J).
A redefinition of trichome nomenclature would be highly desir-
able. In this paper, however, we avoided recommending updated
names to define the gland morphotypes, because an in-depth
study of trichome ontogeny is essential in this regard.Casiraghi A et al. Extraction Method and… Planta Med
▶ Table 1 Experimental conditions related to the heating of canna-
bis flos (series M1, M2, M3) and the extraction in oil (series A, B, C),
as proposed to pharmacists for the compounding of olive oil ex-
tracts.
Heating of cannabis flos
Extraction in oil M1 M2 M3
115 °C for
40min
145 °C for
30min
Room
temperature
A – 70 °C for 40min M1A M2A //
B – 100 °C for 120min M1B M2B M3B
C – 110 °C for 120min // // M3C
▶ Fig. 1 A, B Illustrations of the typical structure of a female inflorescence (A) and of a single female flower (B) in the family Cannabaceae (draw-
ings by M. Bottoni.). C Macrograph showing one of the investigated samples of C. sativa. Note the crowded arrangement of the flowers in the fe-
male inflorescence and the dense pubescence over the plant epidermis. D–G ESEM micrographs. D Leaf adaxial surface showing hooked hair-like
lithocysts (arrows), bulbous (arrow head), and capitate (asterisks) trichomes. E Particulars of the leaf adaxial surface with deeply collapsed epi-
dermal cells and a well-preserved hooked hair-like lithocysts (on the right) and a capitate hair with a short pseudo-stalk (on the left). Note the
breakage of the cuticular sheat and the head cells arranged in a single disc. F Abaxial surface of a pistillate bract showing abundant capitates with
a long pseudo-stalk. Most of them appear headless, with collapsed pseudo-stalks, however, well-preserved glandular heads with intact cuticular
sheats are observed (asterisks). G Particular of the abaxial surface of a pistillate bract. Note the copious secretory products (arrows) covering al-
most the whole capitate trichomes. H–J LM micrographs showing capitate trichomes with long pseudo-stalks. H Hair longitudinal view in bright
field. The secretory products (arrows) flowing along the pseudo-stalk appear dark brownish. I Hair longitudinal view under UV light. The secretory
products (arrows) exhibit primary fluorescence. J Hair crosswise view in bright field evidencing the head cell number and abundant brownish se-
cretory material (arrows).
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l.For the analysis of cannabinoids, a GC/MS and a GC/FID meth-
od were developed and validated. Both methods showed ade-
quate specificity, linearity (Table 1S, Supporting Information), ac-
curacy (Table 2S, Supporting Information), precision (Table 3S,
Supporting Information), limit of detection (LOD), and limit of
quantitation (LOQ) for the evaluation in oily extracts, demonstrat-
ing that besides the MS detector, the FID yielded satisfactory re-
sults.
Both GC methods were therefore used for the analysis of can-
nabinoids contained in several olive oil preparations compounded
by Italian pharmacists according to the conditions reported in
▶ Table 1. Preparation methods consisted of two steps: i. heating
of the cannabis material to obtain cannabinoid decarboxylation,
before the extraction of the active principles (series M1, M2,
M3), and ii. maceration in olive oil (series A, B, C). The results ob-
tained from the analysis of the olive oil preparations with the GC/
FID technique are shown in ▶ Table 2. The results obtained with
the GC/MS method showed concentrations of analytes in the
range ± 0.05% of those obtained with the FID detector.
Pharmacists used all of the six different preparation methods
proposed by SIFAP. Three different treatments of cannabis beforeCasiraghi A et al. Extraction Method and… Planta Medmaceration were applied. Heating at 115°C for 40min (M1) or at
145 °C for 30min (M2) to obtain the conversion of THCA intoTHC.
In the third method (M3), no heating was carried out and, as ex-
pected, in samples 16–18 (▶ Table 2), compounded under condi-
tions M3B (maceration in olive oil at 100°C for 120min) and M3C
(maceration in olive oil at 110°C for 120min), a higher content of
▶ Table 2 Cannabinoid content (% w/w) in olive oil preparations
obtained with standardized medicinal cannabis flos.
Olive oil
preparation
Methoda % THC % THCA
 1 M1A 0.80 0.20
 2 M1A 1.36 0.10
 3 M1B 2.07 < 0.10
 4 M1B 1.27 < 0.10
 5 M1B 1.75 < 0.10
 6 M1B 1.52 0.26
 7 M1B 1.45 < 0.10
 8 M1B 1.88 < 0.10
 9 M1B 1.98 < 0.10
10 M1B 1.91 < 0.10
11 M1B 2.00 < 0.10
12 M2A 1.50 < 0.10
13 M2A 1.24 < 0.10
14 M2B 1.57 < 0.10
15 M2B 1.42 0.16
16 M3B 0.30 1.50
17 M3B 0.55 0.96
18 M3C 0.83 0.69
a Experimental conditions reported in▶ Table 1. THC: delta-9-tetrahy-
drocannabinol, THCA: tetrahydrocannabinolic acid
▶ Fig. 2 Cannabinoid content (% w/w) in seized cannabis heated at
different temperatures for 40min.
▶ Fig. 3 Cannabinoid content (% w/w) in seized cannabis heated at
115 °C for different times.
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l.THCA than that obtained by using other conditions was observed.
On the contrary, when the heating of the plant material was per-
formed, the conversion of THCA into THC was almost complete.
As far as the time and temperature of maceration of the plant ma-
terial in olive oil is concerned, significant differences were de-
tected in only a few cases. In particular, results obtained by using
M1A (heating of the plant material at 115°C for 40min and mac-
eration in olive oil at 70 °C for 40min) or M1B (heating of plant
material at 115 °C for 40min and maceration in olive oil at 100 °C
for 120min) were statistically different (p < 0.05). Nevertheless,
this difference was not revealed in samples obtained using meth-
od M2, maybe due to the very low number of samples prepared.
Taking these preliminary results into consideration, the effect
of heating on the decarboxylation of THCA and the extraction
conditions were further investigated using seized cannabis, ob-
tained by the judicial authority, with the aim of developing a stan-
dardized protocol for this kind of preparation.
As previously discussed, the cannabinoids in flowering tops are
mainly present in acidic form and they can be rapidly converted
into their “neutral” pharmacologically active analogues under
the influence of heat or extended storage. In the case of prepara-
tions intended for oral use, relatively low temperatures are usually
involved. The effect of heating cannabis flowering tops from 85 to
145 °C is shown in ▶ Fig. 2. Heating was performed in a closed
glass container to prevent terpene loss. For comparison, the con-
tent of untreated cannabis is also reported. In this case, a very
mild heating (35 °C) was used to eliminate residual humidity. Upto 100°C, the amount of THC is lower than that of the corre-
sponding acidic cannabinoid. Below 115 °C, the levels of CBN were
always below the LOQ, indicating a low decomposition rate of
THC. The decarboxylation of THCA is complete over 130 °C. At this
temperature, increasing amounts of CBN were measured. CBN is a
product of THC oxidation, and it is a relatively minor constituent in
fresh cannabis. At room temperature, its appearance is due to the
long storage time [23].
The temperature of 115 °C was therefore considered the most
suitable to treat cannabis flowering tops before oil extraction. The
effect of this temperature on THCA decarboxylation in the plant
material kept in the oven for different periods of time was also in-
vestigated (▶ Fig. 3). A prolonged heating time was equivalent to
a higher temperature. The amount of THC improved, but the deg-
radation product was also detected. If a high content of THC is re-
quired, without degradation effects, 115 °C for 40min is the best
condition for the treatment of the flowering tops.
Then, time and temperature of extraction were studied. Re-
sults for the extracted amounts are reported in ▶ Table 3. TheCasiraghi A et al. Extraction Method and… Planta Med
▶ Table 3 Cannabinoid content (% w/w) in olive oil obtained using
heated seized cannabis at different conditions.
Bath temperature (°C) Time (min) % THC % THCA
 70  40 1.21 0.00
100 120 1.52 0.12
100  40 1.55 0.11
THC: delta-9-tetrahydrocannabinol, THCA: tetrahydrocannabinolic acid
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l.lowest temperature seemed to be less efficient in the extraction,
while at 100°C, results obtained after 40 or 120min were not sig-
nificantly different. Therefore, a reduced extraction time was con-
sidered the best option. At this point, the repeatability of the ex-
traction method was evaluated preparing six samples in the opti-
mized conditions. The variability of the concentration of the
active principles in these preparations was limited, as the mean
content of THC, expressed as a percentage, was 1.47 ± 0.14, while
THCA was present in only two samples in the amount of 0.2%
w/w. CBN was never detected.
As repeatability was satisfactory, pharmacists were involved in
the trial of a final standardized protocol: heating of cannabis plant
material at 115 °C for 40min and extraction in oil at 100 °C for
40min. Operating with the optimized conditions, the THC con-
tent (n = 15; mean = 1.55 ± 0.18% w/w) was not significantly dif-
ferent (p = 0.30) with respect to method M1B (▶ Table 1), while
the THCA content was reduced, being equal or below 0.1% w/w.
Samples of these preparations were kept in the refrigerator for
3 weeks and then analyzed again. The results obtained showed
that the cannabis oils were stable and no variation in the THC con-
tent was observed.
In conclusion, this study highlighted that to obtain an olive oil
preparation with a high content of THC, it is mandatory to decar-
boxylate the plant material before the maceration in olive oil. The
analysis of the preparations obtained with the optimized method
showed that it is possible to obtain olive oil extracts with a high
content of THC and these preparations are homogeneous, even
if prepared in different pharmacies. The GC/MS and GC/FID meth-
ods proposed showed features suitable to the analysis of cannabi-
noids contained in oily preparations, demonstrating that it is not
strictly necessary to use an MS detector. In this frame, the devel-
opment of an LC/UV method should be interesting.
This article does not contain any studies using human partici-
pants or animals. Informed consent was obtained from all individ-
uals who participanted in this study.D
ow
nl
oa
deMaterials and Methods
Plant material
C. sativa, a variety containing THC 19–22% w/w (Bedrocan Inter-
national), was used by the pharmacists. C. sativa was obtained
from a judicial seizure, used as a reference standard with the per-
mission of the judicial authority. Due to the restrictions estab-
lished by the Italian Ministry of Health for universities to purchase
medicinal C. sativa “flos”, validation of the analytical methods and
some experimental data were performed using cannabis seized
on the illegal marked.
Botanical identification of all plant material was performed by
Prof. Gelsomina Fico, botanist at the Department of Pharmaceuti-
cal Sciences of the University of Milan.
The voucher specimens consisted of dried female inflores-
cences. The voucher specimen for the marketed C. sativa was pre-
served and deposited at the Ghirardi Botanical Garden of the De-
partment of Pharmaceutical Sciences of the University of Milan
under the accession number 021/DISFARM. The voucher speci-
men for the seized C. sativa was preserved at the Laboratory ofCasiraghi A et al. Extraction Method and… Planta MedChemical and Toxicological Analysis of the Department of Phar-
maceutical Sciences under the accession number 16/47.
Morphological analysis
A morphological investigation on the samples was performed
combining a dual observation approach, macroscopic and micro-
scopic. Firstly, macrographs of the whole intact samples were ob-
tained with a Nikon D3300 digital camera mounted with a Sigma
Lens 105mm F2.8 EX DG Macro Nikon. Afterwards, a micromor-
phological survey on single leaves, pistillate bracts, and the inflo-
rescence axis was carried out by means of light microscopy (LM)
and environmental scanning electron microscopy (ESEM) in order
to document the features of the glandular indumentum. A mini-
mum of four replicates per each investigated plant part was used
for the morphological analysis.
Light microscopy
Hand-made sections of each investigated plant part were ob-
served under a Leitz DM‑RB Fluo Optic microscope equipped with
a digital camera (Nikon DS‑L1). Observations were performed
both in bright field and under UV light to evaluate the primary
fluorescence of trichomes.
Environmental scanning electron microscopy
Small hand-prepared segments of each plant part were directly
examined and photographed by means of a Philips XL30 ESEM,
operating at 15 kW.
Chemicals and reagents
Olive oil, Eur. Virgin, Ph. Eur. Olea europaea L.CAS Number 8001-
25-0 (Farmalabor). Methanol (MeOH), toluene, O,N‑bis(trimethyl-
silyl)trifluoroacetamide trimethylchlorosiloxane (BSTFA-1%
TMCS), methyl oleate (99% purity), THC 1mg/mL in MeOH (purity
≥ 95.0%), CBD 1mg/mL in MeOH (purity ≥ 95.0%), and CBN 1mg/
mL in MeOH (purity ≥ 95.0%) were purchased from Sigma-Aldrich.
THCA 1mg/mL in acetonitrile (purity ≥ 95.0%) and CBDA 1mg/
mL in acetonitrile (purity ≥ 95.0%) were obtained from Cayman
Chemical Company.
Sample preparation of seized cannabis
50mg of seized cannabis were finely ground and added to 5mL of
methanol. The mixture was vortexed for 1min and allowed to
stand for 1min three times. The mixture was centrifuged
(1789 g, 5 min) and then 50 µL) of the supernatant were with-
drawn and added with 50 µL of the IS solution (methyl oleate,
▶ Fig. 4 a GC/FID chromatogram of cannabis olive oil preparations obtained from non-heated material. b GC/FID chromatogram of cannabis olive
oil preparations obtained from heated material.
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l.175 µg/mL in MeOH). The solvent was evaporated and 50 µL of
BSTFA-1% TMCS and 50 µL of toluene were added. The mixture
was vortexed and heated at 70 °C for 30min.
GC/FID
GC/FID analyses were performed on a Trace 2000 Thermo Elec-
tron GC system (Thermo Fisher Scientific) with an FID detector.
The GC was equipped with a DB-5MS UI 5% diphenyl/95% dime-
thylpolysiloxane (30m × 0.25mm i.d., film thickness 0.25mm)
capillary column (Agilent Technologies).
The GC‑FID system was operated under the following condi-
tions: injector temperature 280°C; split mode; split ratio: 30/1;
split flow: 39mL/min. Helium was used as the carrier gas at a flow
rate of 1.3mL/min. The oven temperature program was as fol-
lows: 200–300°C, 10 °C/min; final isotherm, 2min; detector tem-
perature: 300 °C. Hydrogen and air were used as the detector
gases at a flow rate of 35mL/min and 350mL/min, respectively.
Nitrogen at a flow rate of 20mL/min was used as make-up gas.
Time of analysis, 12min. Retention times of the analytes: CBD-
2TMS, 6.067min; THC‑TMS, 7.068min; CBN‑TMS, 7.718min;
CBDA-3TMS, 7.918min; THCA‑TMS, 9.115min; methyl oleate
(IS), 5043min (▶ Fig. 4).
GC/MS
The analyses were performed on a 5973 Hewlett Packard GC sys-
tem, with a split-splitless injection system and an MS detector
(Hewlett Packard) operated in the electron ionization (EI) mode
(70 eV). The GC was equipped with a Rxi®-5ms (Crossbond®,5%
diphenyl/95% dimethyl polysiloxane, 30m × 0.25mm i.d., film
thickness 0.25mm) capillary column (Restek). The GC/MS condi-
tions were as follows: helium was used as the carrier gas at a flow
rate of 1.2mL/min, splitless mode (0.25min); injector tempera-
ture 280 °C; interface transfer line 300 °C; ion source 230°C; oven
temperature program, initial 70 °C, 40 °C/min up to 180 °C, then
10 °C/min up to 300 °C (6.25min).The MS detector was operated in scan mode, acquiring ions
fromm/z 50 to 600. The total analysis time was 21min. The reten-
tion times of the analytes were: IS (methyl oleate), 8.478min (se-
lected ions: 296, 264, 222m/z); CBD – 2TMS, 9.709min (selected
ions: 390, 337, 301m/z); THC – TMS, 10.748min (selected ions:
386, 371, 315m/z); CBN – TMS, 11.429min (selected ions: 382,
368, 367m/z); CBD – A – 3TMS, 11.704min (selected ions 559,
491, 453m/z); THC – A – 2TMS, 12.908min (selected ions: 487,
502m/z) (▶ Fig. 5).
GC/flame ionization detection and GC/MS validation
The specificity, accuracy, precision and linearity as well as the LOD
and LOQ were evaluated on the olive oil preparations.
The specificity was assessed by analyzing blank olive oil. The
lack of interfering peaks at the same analyte retention times con-
ferred acceptable selectivity.
The linearity of the response was assessed for all the analytes
using reference standards by plotting analyte/IS peak area ratios
versus the percentage of the analyte in the standard solutions.
Linearity was established on the olive oil preparations in the con-
centration range of 0.10–4.00% (w/w) for all analytes (0.10%,
0.25%, 0.50%, 1.00%, 1.50%, 2.00%, 4.00%).
For the evaluation of linearity on the olive oil preparations,
50 µL of each cannabinoid standard solution properly diluted and
50 µL of olive oil were mixed, and 50 µL of the IS solution (methyl
oleate, 175 µg/mL in MeOH) were then added. The solvent was
evaporated and 50 µL of BSTFA-1% TMCS and 50 µL of toluene
were added. The mixture was vortexed and heated at 70 °C for
30min.
The intervals of linearity, the linearity equations, and correla-
tion coefficients of the analytes obtained with the two methods
are reported in Table 1S, Supporting Information, either in the
case of the reference standards or olive oil preparations.
Accuracy was expressed as the percent recovery (% REC) eval-
uated by analyzing, in triplicate, three solutions with a concentra-
tion of 0.50% and three solutions with a concentration of 1.50% ofCasiraghi A et al. Extraction Method and… Planta Med
▶ Fig. 5 a GC/MS chromatogram of cannabis olive oil preparations obtained from non-heated material. b GC/MS chromatogram of cannabis olive
oil preparations obtained from heated material.
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l.all analytes. The averaged results were found to be satisfactory
(Table 2S, Supporting Information).
Intraday precision was assessed by analyzing nine samples with
a concentration of 0.50% and nine with a concentration of 1.50%
of the analytes in the same day. The same samples were also ana-
lyzed on two other different days to evaluate inter-day precision.
The results are reported in Table 3S, Supporting Information.
The LOQ and LOD were also evaluated and were found to be,
respectively, 0.10% and 0.03% for all analytes evaluated as the
concentration of the analyte that gives a signal-to-noise ratio of
at least 10 and 3, respectively.
Effects of preheating
To decarboxylate the acidic cannabinoids naturally present in
plant material, seized cannabis was put in a closed glass vial and
heated in an oven (T 5050 E, Heraeus) at 85, 100, 115, 130,
145 °C for 40min. Unheated samples were used as a control for
these experiments.
Olive oil extract preparation
Standardized medicinal cannabis flos: 5 g of cannabis were finely
ground and added to 50mL of olive oil. A mixer was used to
further crumble the plant material. Then, the open beaker was
put in a silicone oil bath preheated at fixed temperatures (70,
100, 110°C). The mixture was stirred for 40min or 120min and
then immediately filtered to obtain the final oil according to
methods reported in ▶ Table 1.
Seized cannabis: a hashish sample seized by the judicial author-
ity was used for the study of the extraction conditions. The com-
position, reported as % w/w, was CBD = 1.45%, THC = 14.49%,
CBN = 0.66%, CBDA = 2.01%, and THCA = 4.11%. 5 g of cannabis
were finely ground and added to 50mL of olive oil. A mixer was
used to further crumble the plant material. Then, the open beaker
was put in a silicone oil bath preheated at fixed temperatures (70,
100 °C). The mixture was stirred for 40min or 120min and then
immediately filtered by using three layers of a commercial gauze
(Stericompress, sterile gauze bandages, 100% cotton, PIC solu-
tion) to obtain the final oil.Casiraghi A et al. Extraction Method and… Planta MedSupporting information
Range of linearity, linearity equations, and correlation coefficients
(Table 1S), accuracy (Table 2S), and precision (Table 3S) for the
two analytical methods are available as Supporting Information
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